| Katherine Nickley, MD | |
|
3 Meeting House Rd, Chelmsford, MA 01824 | |
| (978) 256-5557 | |
| (278) 256-1835 |
| Full Name | Katherine Nickley |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 11 Years |
| Location | 3 Meeting House Rd, Chelmsford, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598008997 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 274669 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lowell General Hospital | Lowell, MA | Hospital |
| Southern Nh Medical Center | Nashua, NH | Hospital |
| Emerson Hospital - | W concord, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts Ent Associates Inc | 6305891110 | 14 |
| Massachusetts Ent Associates Inc | 6305891110 | 14 |
News Archive
Agenus Inc., announced final results from a single-arm, multi-institutional, open-label, Phase 2 study showing that patients with newly diagnosed glioblastoma multiforme (GBM) who received Agenus' Prophage autologous cancer vaccine added to the standard of care treatment, lived nearly twice as long as expected.
UnitedHealthcare's Golden Rule Insurance Company is introducing two new short term health insurance plans in North Carolina and West Virginia designed to meet people's needs for more flexible and cost-effective approaches to coverage.
Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited has received pricing approval for NESINA® (alogliptin) in Japan. NESINA, a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, received regulatory approval from the Japanese Ministry of Health, Labour and Welfare on April 16, 2010. Furiex collaborated with Takeda to develop this product.
Sepsis, commonly called blood poisoning, is a common affliction that can affect people of all ages. A series of simple measures tested at a Norwegian hospital can make a difference in successfully treating sepsis.
› Verified 6 days ago
| Entity Name | Massachusetts Ent Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063493492 PECOS PAC ID: 6305891110 Enrollment ID: O20150205000384 |
News Archive
Agenus Inc., announced final results from a single-arm, multi-institutional, open-label, Phase 2 study showing that patients with newly diagnosed glioblastoma multiforme (GBM) who received Agenus' Prophage autologous cancer vaccine added to the standard of care treatment, lived nearly twice as long as expected.
UnitedHealthcare's Golden Rule Insurance Company is introducing two new short term health insurance plans in North Carolina and West Virginia designed to meet people's needs for more flexible and cost-effective approaches to coverage.
Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited has received pricing approval for NESINA® (alogliptin) in Japan. NESINA, a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, received regulatory approval from the Japanese Ministry of Health, Labour and Welfare on April 16, 2010. Furiex collaborated with Takeda to develop this product.
Sepsis, commonly called blood poisoning, is a common affliction that can affect people of all ages. A series of simple measures tested at a Norwegian hospital can make a difference in successfully treating sepsis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Nickley, MD 3 Meeting House Rd, Chelmsford, MA 01824-2738 Ph: (978) 256-5557 | Katherine Nickley, MD 3 Meeting House Rd, Chelmsford, MA 01824 Ph: (978) 256-5557 |
News Archive
Agenus Inc., announced final results from a single-arm, multi-institutional, open-label, Phase 2 study showing that patients with newly diagnosed glioblastoma multiforme (GBM) who received Agenus' Prophage autologous cancer vaccine added to the standard of care treatment, lived nearly twice as long as expected.
UnitedHealthcare's Golden Rule Insurance Company is introducing two new short term health insurance plans in North Carolina and West Virginia designed to meet people's needs for more flexible and cost-effective approaches to coverage.
Furiex Pharmaceuticals, Inc. today confirmed that Takeda Pharmaceutical Company Limited has received pricing approval for NESINA® (alogliptin) in Japan. NESINA, a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes, received regulatory approval from the Japanese Ministry of Health, Labour and Welfare on April 16, 2010. Furiex collaborated with Takeda to develop this product.
Sepsis, commonly called blood poisoning, is a common affliction that can affect people of all ages. A series of simple measures tested at a Norwegian hospital can make a difference in successfully treating sepsis.
› Verified 6 days ago
Chandra K Khasgiwala, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 160 Turnpike Rd, 2nd Floor, Chelmsford, MA 01824 Phone: 978-328-1016 | |
Eric H Stein, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Meeting House Rd, Ste 24, Chelmsford, MA 01824 Phone: 978-256-5557 Fax: 978-256-1835 | |
Vijay K Nayak, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Meeting House Rd, Suite 24, Chelmsford, MA 01824 Phone: 978-256-5557 Fax: 978-256-1835 | |
Vishnu Kannabiran, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Meeting House Rd, Chelmsford, MA 01824 Phone: 978-256-5557 Fax: 978-256-1835 | |
Arthur M Lauretano, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Meeting House Rd, Suite 24, Chelmsford, MA 01824 Phone: 978-256-5557 Fax: 978-256-1835 | |
Jessica Lauren Hootnick, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3 Meeting House Rd, Chelmsford, MA 01824 Phone: 978-256-5557 Fax: 978-256-1835 | |
Bjorn Bie, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3 Meeting House Rd, Suite 24, Chelmsford, MA 01824 Phone: 978-256-5557 Fax: 978-256-1835 |